Aaron Cox - Dec 27, 2022 Form 4 Insider Report for Horizon Therapeutics Public Ltd Co (HZNP)

Role
EVP, Chief Financial Officer
Signature
/s/ Patrick McIlvenny, Attorney-in-Fact
Stock symbol
HZNP
Transactions as of
Dec 27, 2022
Transactions value $
$0
Form type
4
Date filed
12/29/2022, 03:23 PM
Previous filing
May 16, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HZNP Ordinary Shares Award +277 +5.8% 5.05K Jun 1, 2022 Direct F1
transaction HZNP Ordinary Shares Gift $0 -4.77K -94.52% $0.00 277 Dec 15, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HZNP Performance Restricted Stock Units (PSUs) Award $0 +17.4K $0.00 17.4K Dec 27, 2022 Ordinary Shares 17.4K Direct F2, F3
transaction HZNP Performance Restricted Stock Units (PSUs) Award $0 +14K $0.00 14K Dec 27, 2022 Ordinary Shares 14K Direct F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 277 ordinary shares of the Issuer acquired by the reporting person on June 1, 2022 pursuant to an employee stock purchase program.
F2 Each PSU represents a contingent right to receive one ordinary share of the Issuer.
F3 On January 3, 2020, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. The ordinary shares subject to the PSUs vest on December 30, 2022.
F4 On January 4, 2021, the reporting person was granted performance-based restricted stock units (PSUs) of the Issuer, which vest upon the satisfaction of certain performance criteria. On December 27, 2022, such performance criteria were met. Two-thirds of the ordinary shares subject to the PSUs vest on December 30, 2022, and the remaining one-third of the ordinary shares vest on January 5, 2024.